サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434621

喘息スペーサ市場：製品タイプ、流通チャネル別-2024-2030年の世界予測

Asthma Spacers Market by Product Type (Aerochamber, Inspirease, Optichamber), Distribution Channel (Offline, Online) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
喘息スペーサ市場：製品タイプ、流通チャネル別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

喘息スペーサ市場規模は2023年に18億6,000万米ドルと推計され、2024年には19億6,000万米ドルに達し、CAGR 5.41%で2030年には26億9,000万米ドルに達すると予測されます。

喘息スペーサの世界市場

主な市場の統計
基準年[2023］ 18億6,000万米ドル
予測年[2024］ 19億6,000万米ドル
予測年 [2030] 26億9,000万米ドル
CAGR（%） 5.41%
喘息スペーサ Market-IMG1

喘息スペーサーは、喘息患者の呼吸状態を効果的に管理するために設計された医療機器です。喘息スペーサは定量吸入器（MDI）と共に使用され、患者の気道に直接薬剤を送り込みます。呼吸器疾患の世界の有病率の増加と効率的なドラッグデリバリー機器の必要性により、患者による喘息スペーサの採用が増加しています。喘息管理のための政府の取り組みやプログラムも、喘息スペーサの採用に貢献しています。しかし、喘息スペーサの製造上の欠陥や安全基準を満たさないことによるリコールの発生は、喘息患者の使用に悪影響を及ぼす可能性があります。また、研究開発の活発化により、新しいバリエーションや製品が発売され、治療成績の向上や喘息スペーサの患者への普及が世界中で期待されています。

地域別の洞察

喘息スペーサ市場は、喘息の有病率と呼吸器疾患に対する意識の高まり、技術的に進歩したスペーサーの利用可能性により、南北アメリカで発展しています。急速な都市化と呼吸器疾患の原因となる汚染レベルの急増が、APAC地域における喘息スペーサの需要を増大させています。EMEA地域では、小児喘息の有病率が高く、早期発見と適切なスペーサーを用いた管理が重視されているため、喘息スペーサの採用が加速しています。さらに、最適なドラッグデリバリーを促進し、吸入性能を向上させる喘息スペーサーデザインの継続的な進歩により、世界中の喘息患者による喘息スペーサーの採用が増加すると予想されます。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは喘息スペーサ市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、喘息スペーサ市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-喘息スペーサ市場の市場規模および予測は？

2-喘息スペーサ市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-喘息スペーサ市場における技術動向と規制の枠組みは？

4-喘息スペーサ市場における主要ベンダーの市場シェアは？

5-喘息スペーサ市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で呼吸器疾患の有病率が増加
      • 喘息管理のための政府の取り組みとプログラム
    • 抑制要因
      • 喘息スペーサの想起の発生率
    • 機会
      • 新しいバリエーションや製品を発売するための研究開発の強化
      • 小児喘息患者向け喘息スペーサーの開発
    • 課題
      • 喘息スペーサの技術的および操作上の制限
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 喘息スペーサ市場：製品タイプ別

  • エアロチャンバー
  • インスピレーション
  • 視鏡室
  • ボリュームのある

第7章 喘息スペーサ市場：流通チャネル別

  • オフライン
  • オンライン

第8章 南北アメリカの喘息スペーサ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の喘息スペーサ市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの喘息スペーサ市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 新製品発売と機能強化
    • 受賞・表彰・拡大

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AbbVie Inc.
    • Advin Health Care
    • Air Liquide Medical Systems S.A.
    • AstraZeneca PLC
    • Bird Healthcare Pty Ltd.
    • Cipla Limited
    • EChamber
    • Haag-Streit Group
    • Koninklijke Philips N.V.
    • Lupin Limited
    • Medical Developments International Limited
    • Monaghan Medical Corporation
    • Pari GmbH
    • Respiratory Delivery Systems, Inc.
    • Trudell Medical International
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ASTHMA SPACERS MARKET RESEARCH PROCESS
  • FIGURE 2. ASTHMA SPACERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ASTHMA SPACERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ASTHMA SPACERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ASTHMA SPACERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ASTHMA SPACERS MARKET DYNAMICS
  • FIGURE 7. ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 10. ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ASTHMA SPACERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ASTHMA SPACERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ASTHMA SPACERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ASTHMA SPACERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ASTHMA SPACERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ASTHMA SPACERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ASTHMA SPACERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ASTHMA SPACERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASTHMA SPACERS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ASTHMA SPACERS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ASTHMA SPACERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ASTHMA SPACERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ASTHMA SPACERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ASTHMA SPACERS MARKET SIZE, BY AEROCHAMBER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ASTHMA SPACERS MARKET SIZE, BY INSPIREASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ASTHMA SPACERS MARKET SIZE, BY OPTICHAMBER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ASTHMA SPACERS MARKET SIZE, BY VOLUMATIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. ASTHMA SPACERS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ASTHMA SPACERS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ASTHMA SPACERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ASTHMA SPACERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ASTHMA SPACERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ASTHMA SPACERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ASTHMA SPACERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ASTHMA SPACERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. ASTHMA SPACERS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 100. ASTHMA SPACERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. ASTHMA SPACERS MARKET LICENSE & PRICING
目次
Product Code: MRR-436901065AE4

[197 Pages Report] The Asthma Spacers Market size was estimated at USD 1.86 billion in 2023 and expected to reach USD 1.96 billion in 2024, at a CAGR 5.41% to reach USD 2.69 billion by 2030.

Global Asthma Spacers Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.86 billion
Estimated Year [2024] USD 1.96 billion
Forecast Year [2030] USD 2.69 billion
CAGR (%) 5.41%
Asthma Spacers Market - IMG1

An asthma spacer is a medical device designed to aid individuals with asthma in effectively managing their respiratory condition. Asthma spacers are used with metered-dose inhalers (MDIs), which deliver the medication directly into an individual's airways. The increasing prevalence of respiratory diseases worldwide and the need for efficient drug delivery devices have resulted in increased adoption of asthma spacers by patients. Government initiatives and programs for asthma management are also contributing to adopting asthma spacers. However, incidences of recall of asthma spacers due to manufacturing defects or failure to meet safety standards may adversely impact their use by asthma patients. In addition, rising research and development have led to the launch of new variations and products, which are expected to improve the treatment outcome and encourage patients' adoption of asthma spacers worldwide.

Regional Insights

The asthma spacers market is evolving in the Americas owing to the prevalence of asthma coupled with increasing awareness about respiratory issues and the availability of technologically advanced spacers. Rapid urbanization and surge in pollution levels contributing to respiratory illnesses have augmented the demand for asthma spacers in the APAC region. High prevalence rates of childhood asthma and emphasis on early detection and management using suitable spacer devices have accelerated patients' adoption of asthma spacers in the EMEA regions. Additionally, ongoing advancements in asthma spacer designs to facilitate optimal drug delivery and enhance inhalation performance are anticipated to increase asthma spacer adoption by asthma patients across the globe.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Asthma Spacers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Asthma Spacers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Asthma Spacers Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Advin Health Care, Air Liquide Medical Systems S.A., AstraZeneca PLC, Bird Healthcare Pty Ltd., Cipla Limited, EChamber, Haag-Streit Group, Koninklijke Philips N.V., Lupin Limited, Medical Developments International Limited, Monaghan Medical Corporation, Pari GmbH, Respiratory Delivery Systems, Inc., and Trudell Medical International.

Market Segmentation & Coverage

This research report categorizes the Asthma Spacers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Aerochamber
    • Inspirease
    • Optichamber
    • Volumatic
  • Distribution Channel
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Asthma Spacers Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Asthma Spacers Market?

3. What are the technology trends and regulatory frameworks in the Asthma Spacers Market?

4. What is the market share of the leading vendors in the Asthma Spacers Market?

5. Which modes and strategic moves are suitable for entering the Asthma Spacers Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Asthma Spacers Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of respiratory diseases worldwide
      • 5.1.1.2. Government initiatives and programs for asthama management
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of recall of asthma spacers
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising research and development to launch new variations and products
      • 5.1.3.2. Development of asthma spacer for pediatric asthma patients
    • 5.1.4. Challenges
      • 5.1.4.1. Technical and operational limitations of asthma spacers
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Asthma Spacers Market, by Product Type

  • 6.1. Introduction
  • 6.2. Aerochamber
  • 6.3. Inspirease
  • 6.4. Optichamber
  • 6.5. Volumatic

7. Asthma Spacers Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. Online

8. Americas Asthma Spacers Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Asthma Spacers Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Asthma Spacers Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player
    • 11.3.1. New Product Launch & Enhancement
      • 11.3.1.1. Lupin Unit Introduces Inhaler for Asthma Patients in Germany
      • 11.3.1.2. Ground-Breaking New Asthma Treatment Device Launches in South Africa
    • 11.3.2. Award, Recognition, & Expansion
      • 11.3.2.1. AstraZeneca to Set Up Centers of Excellence for Severe Asthma in India

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. AbbVie Inc.
    • 12.1.2. Advin Health Care
    • 12.1.3. Air Liquide Medical Systems S.A.
    • 12.1.4. AstraZeneca PLC
    • 12.1.5. Bird Healthcare Pty Ltd.
    • 12.1.6. Cipla Limited
    • 12.1.7. EChamber
    • 12.1.8. Haag-Streit Group
    • 12.1.9. Koninklijke Philips N.V.
    • 12.1.10. Lupin Limited
    • 12.1.11. Medical Developments International Limited
    • 12.1.12. Monaghan Medical Corporation
    • 12.1.13. Pari GmbH
    • 12.1.14. Respiratory Delivery Systems, Inc.
    • 12.1.15. Trudell Medical International
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing